Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Surgical Case Reports|January 11, 2020
Synchronous NET and colorectal cancer development: a case reportShinsei Yumoto, Yuji Miyamoto, Takahiko Akiyama, et al.
Pancreas|April 1, 2026
Neoadjuvant Chemotherapy Diminishes Ki-67 Overexpression and Persistent Overexpression is a Poor Prognostic Factor in Pancreatic Ductal Adenocarcinoma After PancreatectomyShinsei Yumoto, Hiromitsu Hayashi, Toru Takematsu, et al.
Oncogene|July 13, 2022
Tumor cell-derived ANGPTL2 promotes β-catenin-driven intestinal tumorigenesisHaruki Horiguchi, Tsuyoshi Kadomatsu, Shinsei Yumoto, et al.
Langenbeck'S Archives of Surgery|January 24, 2024
Prognostic value of preoperative geriatric nutritional risk index in intrahepatic cholangiocarcinoma after hepatectomy: a single‑center retrospective cohort studyDaisuke Ogawa, Tatsunori Miyata, Shinsei Yumoto, et al.
Surgical Case Reports|September 1, 2019
Thyroid metastasis from esophageal adenocarcinoma: a case report and literature reviewShinsei Yumoto, Yoshifumi Baba, Daichi Nomoto, et al.
Cancer Gene Therapy|March 12, 2024
Tumor stroma-derived ANGPTL2 potentiates immune checkpoint inhibitor efficacyHaruki Horiguchi, Tsuyoshi Kadomatsu, Tomoya Yamashita, et al.
Anticancer Research|November 4, 2021
Far-advanced Colorectal Liver Metastases Successfully Managed With Modified ALPPS and Radiofrequency Ablation in Combination With ChemotherapyYuki Adachi, Kensuke Yamamura, Shinsei Yumoto, et al.
International Journal of Clinical Oncology|November 9, 2023
Patient vulnerability is associated with poor prognosis following upfront hepatectomy for colorectal liver metastasisKosuke Mima, Hiromitsu Hayashi, Yuki Adachi, et al.
International Journal of Clinical Oncology|October 22, 2024
Prognostic impact of aspirin in patients with hepatocellular carcinoma after liver resection: propensity-score-matched analysisTakashi Matsumoto, Yuki Kitano, Katsunori Imai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 2, 2024
[The Usefulness of RFA as a Conversion Therapy after Molecular Targeted Therapy for Advanced Hepatocellular Carcinoma-A Case of Long-Term Survival with Multidisciplinary Treatment]Takashi Matsumoto, Hiromitsu Hayashi, Yuki Adachi, et al.
Pageof 4